Corbevax, Covovax gets approved for emergency use authorization against COVID-19 in India
The centre today gave approval to CORBEVAX, COVOVAX for emergency use authorisation as COVID-19 vaccines. Additionally, Molnupiravir, an antiviral drug, has also been approved for restricted use in an emergency situation. This takes the total tally of approved vaccines for emergency use authorization to 8 in the country.
The announcement came from Union Health Minister Mansukh Mandaviya stating that the Central Drugs Standard Control Organisation (CDSCO), which comes under the Ministry of Health and Family Welfare, has given emergency use authorization approval to two COVID-19 vaccines including Covovax and Corbevax.
The minister shared on Twitter that CORBEVAX is India’s 1st indigenously developed RBD protein sub-unit vaccine against COVID-19 and will be made by Hyderabad-based firm Biological-E. COVOVAX, a nanoparticle vaccine, will be manufactured by Pune-based firm Serum Institute of India. He further added that Molnupiravir, which is an antiviral drug, will be manufactured in the country by 13 companies for restricted use under emergency situations for the treatment of adult patients with COVID-19 and who have a high risk of progression of the disease.
“PM Narendra Modi Ji has led the battle against COVID-19 from the front. All these approvals will further strengthen the global fight against the pandemic. Our Pharma Industries are asset for the entire world,” the Health Minister tweeted.
post_id:Congratulations India ??
Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:
– CORBEVAX vaccine
– COVOVAX vaccine
– Anti-viral drug MolnupiravirFor restricted use in emergency situation. (1/5)
— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
